Preclinical Models

CD70-Targeted HIT Cells Eradicate Solid Tumors in Mice

A peer-reviewed Science study reports mouse tumor clearance using ultra-sensitive receptors that detect very low CD70 levels, prompting plans for a first-in-human safety trial.